Efficacy and Safety of Ponatinib as a Second‑Line Treatment for Chronic‑Phase Chronic Myeloid Leukemia: Retrospective Study at Two Japanese Centers

Indian Journal of Hematology and Blood Transfusion 2026 Open access

Read full text
Authors: Yoshimi Ishii, Shin Fujisawa, Katsumichi Fujimaki, Takuya Miyazaki, Yuki Nakajima, Yuto Hibino, Takaaki Takeda, Kosuke Takayama, Itaru Sato, Kota Kawabata, Hideaki Nakajima
DOI: 10.1007/s12288-025-02301-7
Cited by: 0
References: 8

Fields of Study & Subjects

Chronic Myeloid Leukemia Treatments Eosinophilic Disorders and Syndromes Acute Myeloid Leukemia Research

Publication details

Journal / source
Indian Journal of Hematology and Blood Transfusion
Volume
42
Issue
5
Pages
2121–2125
Publication date
5 January 2026
Language
EN